Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation

Article English OPEN
Bellone, Marco; Pradelli, Lorenzo; Bo, Mario;
  • Publisher: SEEd Medical Publishers
  • Journal: Farmeconomia: Health Economics and Therapeutic Pathways (issn: 2240-256X, eissn: 2240-256X)
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.7175/fe.v19i1.1346
  • Subject: Direct oral anticoagulants | Thromboembolic events | R5-920 | Medicine (General) | Direct oral anticoagulants; Thromboembolic events; Non-valvular atrial fibrillation | Non-valvular atrial fibrillation

INTRODUCTION: The direct oral anticoagulants (DOACs) have demonstrated a more predictable effect and a more favorable risk-benefit ratio compared to the standard oral anticoagulant treatment for the prevention of stroke in patients with non-valvular atrial fibrillation ... View more
Share - Bookmark